Robertson JFR, Gogitidze T, Katashvili Z, Rocha JEB, et al. Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study. J Clin Oncol 2026 Jan 16:JCO2501548. doi: 10.1200/JCO-25-01548.
PMID: 41628308